Surfactants and Stabilising Excipients: When Adding Something Helps

When a solution aggregates, the instinct is to add something to stop it. Surfactants, amino acids and sugars all appear in formulation practice for exactly that purpose, and they work. What the published work shows is that they work in narrower and stranger ways than the phrase “stabilising excipient” implies, that two apparently interchangeable additives can protect against completely different things, and that at least one common additive buys its benefit at a measurable cost.

Quick answer

Should you add a surfactant to a peptide solution? Only for a specific reason, and knowing that the choice is still largely empirical. A 2023 study examining two surfactants with a model protein found that neither affected tertiary structure or thermal stability — so they are not stabilising the molecule in the way the name suggests. Both inhibited subvisible particle formation during long-term storage, but only polysorbate 20 reduced the amount of small soluble aggregates detected by size-exclusion chromatography. Two additives, two different protected populations. The authors note plainly that suitable surfactant choice for a given protein is decided mostly empirically and the molecular mechanism is largely unknown.

They are not stabilising the molecule

The mental model most people carry is that a stabilising excipient somehow makes the molecule itself sturdier. The measurements do not support that.

In the study above, circular dichroism and nano differential scanning fluorimetry showed that neither polysorbate 20 nor poloxamer 407 affected the tertiary structure or the thermal stability of the protein. Whatever protection they provided was not conformational.

What saturation transfer difference NMR did detect was a direct interaction: polysorbate 20 binds the protein through its fatty acid chain, and that binding was stronger at pH closer to the isoelectric point. For poloxamer 407, no interaction with the protein was detected at all — yet it still suppressed particle formation.

That pair of results is the useful one. An additive can protect without binding, which points at interfaces rather than at the molecule. Surfactants occupy air-liquid and solid-liquid surfaces, which is where a great deal of aggregation actually initiates — the same mechanism behind the losses in adsorption to surfaces.

Different additives protect different populations

Reading only a particle count, the two look equivalent. Reading size-exclusion chromatography, they do not. This is the same lesson that appears in what haze means: aggregates occupy a size range, methods each see one part of it, and a protective claim is only as broad as the assay that supports it.

The practical implication is that “we added a surfactant and the particles went away” is not the same statement as “the material is intact”.

Additives have costs

A separate study comparing two amino acid excipients makes the point directly. Arginine monohydrochloride is a widely used aggregation suppressor, and in that work it significantly reduced the transition temperature as its concentration increased — the protein became thermally less stable in exchange for the aggregation benefit. An alternative, N-acetyl-L-arginine, retained the transition temperature better while delivering higher monomeric content, lower particle levels and a higher aggregation onset temperature under five days of end-over-end rotation.

So the trade is real and it is measurable in both directions. An excipient that suppresses one failure mode can worsen another, and the only way to know which way a given system lands is to measure both.

The same study also found that in the presence of silicone oil — a common container leachable discussed in what the container adds — the better excipient dramatically reduced an inflammatory marker, which ties additive choice back to contamination the solution did not start with.

When adding something is justified

The fourth row is worth emphasising because it is the most common misuse. A surfactant does not increase solubility in the thermodynamic sense; it reduces interfacial loss and interface-driven association. Haze on first dissolution is a different problem.

Practical notes

• Change one thing. Adding an excipient while also changing container or buffer makes the result uninterpretable.
• Put it in the control. Any additive present in the test condition belongs in the vehicle control at the same concentration, for the same reasons set out in DMSO and solvent controls.
• Check pH against the isoelectric point. Surfactant binding was stronger near the pI in the study above, and the pI is also where charge repulsion is weakest. See peptide buffers and pH.
• Verify with more than one method. A particle count and a size-exclusion run answer different questions, and an additive can pass one while failing the other.
• Remember it does not come out. Surfactants pass through sterilising filters and stay in the solution. Like a preservative, the decision is effectively permanent once made — see benzyl alcohol and preservatives.
• Record it. Identity, grade and concentration. An unrecorded excipient is an unreproducible solution.

Key takeaways

• Surfactant choice for a given protein is still decided mostly empirically, and the molecular mechanism is largely unknown.
• Neither of two surfactants studied affected tertiary structure or thermal stability — they are not stabilising the molecule conformationally.
• Polysorbate 20 bound the protein through its fatty acid, more strongly near the isoelectric point; poloxamer 407 showed no detectable binding and still suppressed particles.
• Both inhibited subvisible particles, but only polysorbate 20 reduced small soluble aggregates by SEC. Different additives protect different populations.
• Excipients carry costs: arginine hydrochloride significantly reduced the transition temperature as concentration rose.
• Surfactants do not increase thermodynamic solubility. Haze on first dissolution is a diluent problem.
• Additives pass through sterilising filters and stay in the solution. The decision is effectively permanent.

Frequently asked questions

Will a surfactant stop my peptide sticking to plastic?

It can reduce interfacial loss, which is the mechanism behind a lot of apparent disappearance at low concentration. Before adding one, consider whether a different container, a higher working concentration or a smaller tube would solve the geometry problem instead, since those add no new variable.

Which surfactant should I use?

The honest answer is that the literature does not provide a general rule — the study cited here says the choice is made mostly empirically. If an additive is genuinely needed, the defensible approach is to test the specific option in the specific system and measure more than one aggregate population.

Does adding a surfactant change my concentration measurement?

It can. Surfactants absorb in the ultraviolet to varying degrees and alter surface behaviour in cuvettes. Any blank must contain the same additive at the same concentration. See measuring peptide concentration.

Is a sugar or an amino acid safer than a surfactant?

Not inherently. The arginine result above shows an amino acid excipient reducing thermal stability while improving aggregation resistance. Every additive is a trade; the question is which failure mode matters in your system.

Can I add it after the fact to rescue a hazy solution?

Generally no. Covalent aggregates do not reverse, and a surfactant is a preventive against interface-driven association rather than a solubiliser. If the haze is solubility-limited, the fix is the diluent.

Sources

• Svilenov HL, Kopp KT, Golovanov AP, Winter G, Zalar M. Insights into the stabilization of interferon alpha by two surfactants revealed by STD-NMR spectroscopy. J Pharm Sci. 2023;112(2):404–410. DOI
• Kim NA, Noh GY, Hada S, Na KJ, Yoon HJ, Park KW, Park YM, Jeong SH. Enhanced protein aggregation suppressor activity of N-acetyl-l-arginine for agitation-induced aggregation with silicone oil and its impact on innate immune responses. Int J Biol Macromol. 2022;216:42–51. DOI

Citations retrieved via PubMed. These studies were performed on therapeutic proteins; the mechanisms transfer, the specific choices and magnitudes do not.

This article describes formulation chemistry and laboratory practice only. It contains no usage instructions, no dosing information and no protocols of any kind.

For laboratory and in-vitro research use only. Not for human or veterinary use.